There is little research detailing the changes There is little research detailing the changes to the human brain as a result of chronic to the human brain as a result of chronic opioid use and in early abstinence. We have opioid use and in early abstinence. We have previously used [ previously used [ 11 11 C]-diprenorphine positron C]-diprenorphine positron emission tomography (PET) to measure emission tomography (PET) to measure levels of available opioid receptors in the levels of available opioid receptors in the brain of patients on methadone maintebrain of patients on methadone maintenance, but found no detectable occupancy nance, but found no detectable occupancy by methadone (Melichar by methadone (Melichar et al et al, 2005) . Other , 2005) . Other PET studies have reported that increased PET studies have reported that increased binding of [ binding of [ 11 11 C]-carfentanil in withdrawal C]-carfentanil in withdrawal and abstinence in cocaine and alcohol deand abstinence in cocaine and alcohol dependence is associated with craving (Zubiependence is associated with craving (Zubieta ta et al et al, 1996; Gorelick , 1996; Gorelick et al et al, 2005; Heinz , 2005; Heinz et et al al, 2005) . A preliminary , 2005) . A preliminary study also restudy also reported an increase in [ ported an increase in [ 11 11 C]-C]-carfentanil carfentanil binding in people with opioid dependence binding in people with opioid dependence who were briefly maintained on buprenorwho were briefly maintained on buprenorphine (Zubieta phine (Zubieta et al et al, 2000) . In this study , 2000). In this study we present data on the binding of the we present data on the binding of the opioid receptor PET tracer [ opioid receptor PET tracer [ 11 11 C]-diprenor-C]-diprenorphine, which labels phine, which labels m m, , k k and and d d opioid recepopioid receptors, in people with opioid dependence tors, in people with opioid dependence during early abstinence. We measured during early abstinence. We measured [ [ 11 11 C]-diprenorphine binding in brain areas C]-diprenorphine binding in brain areas implicated in dependence and its relationimplicated in dependence and its relationship to clinical variables. Our hypothesis ship to clinical variables. Our hypothesis was that in people with opioid addiction, was that in people with opioid addiction, opioid receptor availability would be inopioid receptor availability would be increased in early abstinence and that this creased in early abstinence and that this would be related to craving. would be related to craving.
METHOD METHOD Participants Participants
We recruited ten people with opioid depenWe recruited ten people with opioid dependence (8 male, 2 female; mean age 31.7 dence (8 male, 2 female; mean age 31.7 years, s.d. years, s.d.¼6.3, range 25-45) undergoing 6.3, range 25-45) undergoing in-patient detoxification at Bristol Speciain-patient detoxification at Bristol Specialist Drug Service (Bristol, UK). All fulfilled list Drug Service (Bristol, UK). All fulfilled DSM-IV criteria for opioid dependence DSM-IV criteria for opioid dependence (American Psychiatric Association, 1994) (American Psychiatric Association, 1994) prior to detoxification but were excluded prior to detoxification but were excluded if they fulfilled diagnostic criteria for anif they fulfilled diagnostic criteria for another current Axis I disorder (excluding other current Axis I disorder (excluding nicotine dependence). The participants were nicotine dependence). The participants were in their 10th day of a lofexidine-assisted in their 10th day of a lofexidine-assisted in-patient detoxification regime from in-patient detoxification regime from methadone and were free of opioids or methadone and were free of opioids or any other drug of misuse as confirmed by any other drug of misuse as confirmed by urinalysis at the time of scanning. They urinalysis at the time of scanning. They were typically long-standing opioid users were typically long-standing opioid users and had been on methadone for a mean and had been on methadone for a mean of 6.9 years (s.d. of 6.9 years (s.d.¼5.2, range 2-17 years); 5.2, range 2-17 years); the mean dose at the start of detoxification the mean dose at the start of detoxification was 31 mg/day (s.d. was 31 mg/day (s.d.¼12, range 15-50). The 12, range 15-50). The patients had a history of using a variety of patients had a history of using a variety of other drugs prior to admission (Table 1) ; other drugs prior to admission (Table 1) ; all but one participant continued to use all but one participant continued to use heroin in addition to their prescribed heroin in addition to their prescribed methadone in the month prior to detoxifimethadone in the month prior to detoxification, half were using 'crack' cocaine prior cation, half were using 'crack' cocaine prior to detoxification and all were tobacco smoto detoxification and all were tobacco smokers. All participants underwent the standkers. All participants underwent the standard detoxification regimen under the care ard detoxification regimen under the care of the clinical team, independent of the of the clinical team, independent of the investigators. investigators.
Twenty healthy people (18 male, 2 feTwenty healthy people (18 male, 2 female; mean age 34.8 years, s.d. male; mean age 34.8 years, s.d.¼8.3, range 8.3, range 25-48) with no history of dependence on 25-48) with no history of dependence on any drug except nicotine (all current nonany drug except nicotine (all current nonsmokers) were recruited as controls. Consmokers) were recruited as controls. Controls had no history of serious psychiatric trols had no history of serious psychiatric or medical disorder as determined by clinior medical disorder as determined by clinical interview. They were recruited for this cal interview. They were recruited for this and other studies to form a common pool, and other studies to form a common pool, to avoid unnecessary duplication and radiato avoid unnecessary duplication and radiation exposure. Therefore, only 8 of the 20 tion exposure. Therefore, only 8 of the 20 controls completed all the same questioncontrols completed all the same questionnaires as participants with opioid depennaires as participants with opioid dependence. The control group for this study dence. The control group for this study was selected to match the age range of was selected to match the age range of participants with opioid dependence. participants with opioid dependence.
Local research ethics committees and Local research ethics committees and the UK Administration of Radioactive Subthe UK Administration of Radioactive Substances Advisory Committee approved all stances Advisory Committee approved all procedures and experimental protocols. procedures and experimental protocols. After full explanation of the study proceAfter full explanation of the study procedures, volunteers gave written informed dures, volunteers gave written informed consent. consent.
Clinical measures Clinical measures
Subjective measures included the Adjective Subjective measures included the Adjective Checklist (Jasinski, 1997), which measures Checklist (Jasinski, 1997), which measures effects of opioid agonists (16 items) and effects of opioid agonists (16 items) and opioid withdrawal symptoms (21 items), opioid withdrawal symptoms (21 items), and the 49-item short form of the Addiction and the 49-item short form of the Addiction Research Centre Inventory (ARCI), which Research Centre Inventory (ARCI), which is scored for euphoria, dysphoria and sedais scored for euphoria, dysphoria and sedation scales (Haertzen, 1970) . tion scales (Haertzen, 1970) .
Objective evidence of withdrawal (OpiObjective evidence of withdrawal (Opiate Withdrawal Scale; OWS) was measured ate Withdrawal Scale; OWS) was measured using an adaptation of the Kolb and using an adaptation of the Kolb and Himmelsbach point system as previously Himmelsbach point system as previously described (Law described (Law et al et al, 1997) . Drug craving , 1997). Drug craving was assessed using two tools; the 45-item was assessed using two tools; the 45-item Heroin Craving Questionnaire (HCQ; Heroin Craving Questionnaire (HCQ; Weinstein Weinstein et al et al 1997) and the Obsessive 1997) and the Obsessive Compulsive Drinking Scale (OCDS), Compulsive Drinking Scale (OCDS), adapted to measure opioid compulsive beadapted to measure opioid compulsive behaviour and obsessive thoughts, and allowhaviour and obsessive thoughts, and allowing for mode of drug delivery (Anton ing for mode of drug delivery (Anton et al et al 1996) . Two experienced addiction clini-1996) . Two experienced addiction clinicians (T.W. and M.D.) independently rated cians (T.W. and M.D.) independently rated each patient for the amount of opioids used each patient for the amount of opioids used in the month and year prior to scanning, as in the month and year prior to scanning, as well as lifetime use, using a structured well as lifetime use, using a structured rating scheme taking into account the comrating scheme taking into account the combination of opioids used, length and route bination of opioids used, length and route of use. We also looked for associations with of use. We also looked for associations with published post-mortem data reporting published post-mortem data reporting regional densities of regional densities of m m opioid receptors opioid receptors (Pfeiffer (Pfeiffer et al et al, 1982 (Pfeiffer et al et al, ). , 1982 C]-diprenorphine C]-diprenorphine was given intravenously over 30 s. Dynamic was given intravenously over 30 s. Dynamic emission data were acquired over 90 min, emission data were acquired over 90 min, in 18 time frames (27 frames for 9 controls) in 18 time frames (27 frames for 9 controls) and reconstructed into 31 contiguous horiand reconstructed into 31 contiguous horizontal image planes (Jones zontal image planes (Jones et al et al, 1994) . , 1994). Radioactivity in arterial blood was assayed Radioactivity in arterial blood was assayed continuously online in accordance with a continuously online in accordance with a standard protocol and discrete blood standard protocol and discrete blood samples were taken every 5-10 min for samples were taken every 5-10 min for assay of radiolabelled metabolites in assay of radiolabelled metabolites in plasma (Ranicar plasma (Ranicar et al et al, 1991) . , 1991).
Image processing and statistical Image processing and statistical analysis analysis
The dynamic PET scans were analysed to The dynamic PET scans were analysed to produce parametric images of ligand produce parametric images of ligand volume of distribution using spectral analyvolume of distribution using spectral analysis with in-house receptor parametric mapsis with in-house receptor parametric mapping software implemented in Matlab ping software implemented in Matlab (Mathworks Inc., Natick, Massachusetts) (Mathworks Inc., Natick, Massachusetts) (Gunn (Gunn et al et al, 2002) . Spectral analysis with , 2002). Spectral analysis with individual metabolite corrected plasma inindividual metabolite corrected plasma input function takes account of any difference put function takes account of any difference in tracer delivery between individuals or in tracer delivery between individuals or groups. The volume of distribution is the groups. The volume of distribution is the ratio of total free and bound tissue to free ratio of total free and bound tissue to free plasma ligand concentration at equilibrium plasma ligand concentration at equilibrium and provides an index of receptor binding. and provides an index of receptor binding. C]-diprenorphine template C]-diprenorphine template created inhouse from the PET scans of created inhouse from the PET scans of seven healthy volunteers. seven healthy volunteers.
We performed two types of analysis, We performed two types of analysis, first using predefined volumes of interest first using predefined volumes of interest and then using SPM2 for an exploratory and then using SPM2 for an exploratory analysis. Twenty-one regions for which we analysis. Twenty-one regions for which we had an had an a priori a priori hypothesis for increased hypothesis for increased opioid receptor availability based on opioid receptor availability based on previous studies were selected for compariprevious studies were selected for comparison. These areas were the orbito-frontal son. These areas were the orbito-frontal cortex, anterior cingulate, ventral striatum cortex, anterior cingulate, ventral striatum (including the nucleus accumbens), dorsal (including the nucleus accumbens), dorsal striatum (including the caudate nucleus striatum (including the caudate nucleus and putamen), thalamus, amygdala and and putamen), thalamus, amygdala and periaqueductal grey matter. All these reperiaqueductal grey matter. All these regions have been shown to have a role in gions have been shown to have a role in the addiction process. The anterior cinguthe addiction process. The anterior cingulate cortex, orbitofrontal cortex, nucleus late cortex, orbitofrontal cortex, nucleus accumbens and amygdala are key in reward accumbens and amygdala are key in reward and motivation during drug-using from the and motivation during drug-using from the evaluation of stimuli to reward-based decievaluation of stimuli to reward-based decision-making and learning. The periaquesion-making and learning. The periaqueductal grey matter is an important element ductal grey matter is an important element of the endogenous opioid system and is inof the endogenous opioid system and is involved in conditioned processes in depenvolved in conditioned processes in dependent drug use. Similarly the thalamus, dent drug use. Similarly the thalamus, caudate and putamen form part of the emocaudate and putamen form part of the emotional reward neurocircuitry which has an tional reward neurocircuitry which has an important role in motivational factors and important role in motivational factors and links to motor pathways, possibly being a links to motor pathways, possibly being a route for the development of locomotor route for the development of locomotor sensitisation with continued drug use sensitisation with continued drug use The volume of distribution maps were sampled using the individualised atlas were sampled using the individualised atlas for every participant to generate mean for every participant to generate mean volume of distribution values for each volume of distribution values for each volume of interest. These values were then volume of interest. These values were then compared between groups using a twocompared between groups using a twotailed non-paired tailed non-paired t t-test -unequal variances -test -unequal variances were assumed. Pearson's correlation statiswere assumed. Pearson's correlation statistics were used to assess the association of tics were used to assess the association of clinical variables with opioid receptor clinical variables with opioid receptor binding. binding.
In addition, [ In addition, [ 11 11 C]-diprenorphine volume C]-diprenorphine volume of distribution images were analysed on a of distribution images were analysed on a voxel-by-voxel basis using SPM2. Spatially voxel-by-voxel basis using SPM2. Spatially normalised parametric images were normalised parametric images were smoothed with a 12 mm kernel at full width smoothed with a 12 mm kernel at full width half maximum. Mean differences between half maximum. Mean differences between groups were interrogated using groups were interrogated using non-paired non-paired t t-tests, and correlations between -tests, and correlations between clinical clinical variables and [ variables and [ 11 11 C]-diprenorphine binding C]-diprenorphine binding were explored using linear regression withwere explored using linear regression within the general linear model in SPM2. in the general linear model in SPM2. Proportional scaling was used to normalise Proportional scaling was used to normalise global differences throughout. For regions global differences throughout. For regions where there existed an where there existed an a priori a priori hypothesis, hypothesis, results are reported as significant at a results are reported as significant at a threshold of threshold of P P5 50.05 uncorrected. For all 0.05 uncorrected. For all other areas familywise error correction other areas familywise error correction was used. was used.
6 4 6 4 AUTHOR'S PROOF AUTHOR'S PROOF 
RESULTS RESULTS

Clinical measures Clinical measures
At the time of scanning, there was no At the time of scanning, there was no clinically significant opioid withdrawal as clinically significant opioid withdrawal as measured by the OWS (mean score 1.2, measured by the OWS (mean score 1.2, s.d. s.d.¼1.2, range 0-3). However the subjec-1.2, range 0-3). However the subjective ARCI and Adjective Checklist showed tive ARCI and Adjective Checklist showed higher measures of withdrawal in particihigher measures of withdrawal in participants with opioid dependence than in conpants with opioid dependence than in controls. They showed significantly higher trols. They showed significantly higher state, but not trait, anxiety than controls state, but not trait, anxiety than controls on the day of their scan. Participants with on the day of their scan. Participants with opioid dependence scored significantly lowopioid dependence scored significantly lower than controls on some measures of health er than controls on some measures of health (Table 2) . On the personality question- (Table 2 ). On the personality questionnaires participants with opioid dependence naires participants with opioid dependence scored significantly higher for psychotiscored significantly higher for psychoticism, extraversion, impulsiveness and vencism, extraversion, impulsiveness and venturesomeness than controls, but not for turesomeness than controls, but not for neuroticism or empathy. neuroticism or empathy.
All v. 17.1, 11.4% increase, 95% CI 17.1, 11.4% increase, 95% CI 2.1-20.7, 2.1-20.7, P P¼0.019). In 15 of the 21 0.019). In 15 of the 21 a priori a priori regions studied there was a significant inregions studied there was a significant increase in volume of distribution in people crease in volume of distribution in people with opioid dependence when compared with opioid dependence when compared with controls ( with controls (P P5 50.05 uncorrected). These 0.05 uncorrected). These were the brain-stem, right amygdala, left were the brain-stem, right amygdala, left medial orbital cortex and bilateral anterior medial orbital cortex and bilateral anterior cingulate, putamen, thalamus, and anterior, cingulate, putamen, thalamus, and anterior, lateral and posterior orbitofrontal cortex. lateral and posterior orbitofrontal cortex. Only the left lateral orbital area remained Only the left lateral orbital area remained significant if these areas are considered significant if these areas are considered independent and the overly conservative independent and the overly conservative Bonferroni correction is applied ( Bonferroni correction is applied (P P¼0.042, 0.042, corrected). There was no significant assocorrected). There was no significant association between age and global [ ciation between age and global [ 11 11 C]-dipre-C]-diprenorphine volume of distribution for the norphine volume of distribution for the whole group ( whole group (n n¼30, 30, r r¼7 70.30, 0.30, P P¼0.105) 0.105) or when the control ( or when the control (n n¼20, 20, r r¼7 70.31, 0.31, P P¼0.184) and opiod-dependent groups 0.184) and opiod-dependent groups ( (n n¼10, 10, r r¼7 70.02, 0.02, P P¼0.962) were analysed 0.962) were analysed separately. separately.
6 5 6 5 AUTHOR'S PROOF AUTHOR'S PROOF C]-diprenorphine binding was found C]-diprenorphine binding was found when the participants with opioid depenwhen the participants with opioid dependence were divided into two groups: dence were divided into two groups: short-term users (use for under 10 years) short-term users (use for under 10 years) and long-term users (use for more than 10 and long-term users (use for more than 10 years). We found no significant effect for years). We found no significant effect for either alcohol or 'crack' cocaine on [ either alcohol or 'crack' cocaine on [ 11 11 C]-C]-diprenorphine binding by comparing those diprenorphine binding by comparing those that had used in the previous 30 days with that had used in the previous 30 days with those that had not. Of interest, although it those that had not. Of interest, although it did not achieve significance, was a trend todid not achieve significance, was a trend towards a negative correlation between level of wards a negative correlation between level of opioid use in the previous month, year or opioid use in the previous month, 
DISCUSSION DISCUSSION
This is the first study, to our knowledge, This is the first study, to our knowledge, that has studied opioid receptor binding that has studied opioid receptor binding using [ using [ 11 11 C]-diprenorphine PET in people C]-diprenorphine PET in people with opioid dependence undergoing recent with opioid dependence undergoing recent detoxification. We found a significant indetoxification. We found a significant increase in [ crease in [ 11 11 C]-diprenorphine volume of C]-diprenorphine volume of distribution in the majority of distribution in the majority of a priori a priori regions of interest, although notably not regions of interest, although notably not in the nucleus accumbens or caudate nuin the nucleus accumbens or caudate nucleus. Exploratory statistical parametric cleus. Exploratory statistical parametric mapping at a threshold for significance apmapping at a threshold for significance applying a full correction for multiple complying a full correction for multiple comparisons identified the right fusiform and parisons identified the right fusiform and right parahippocampal gyri as areas of right parahippocampal gyri as areas of significantly increased binding. At a lower significantly increased binding. At a lower threshold, the mapping confirmed the findthreshold, the mapping confirmed the findings of the volume of interest analysis when ings of the volume of interest analysis when applied to regions specified applied to regions specified a priori a priori. .
Opioid receptor availability Opioid receptor availability in dependence in dependence
There is limited preclinical research that There is limited preclinical research that helps to interpret the results of this study. helps to interpret the results of this study.
Although it is clear that chronic opioid Although it is clear that chronic opioid exposure leads to reduced opioid receptor exposure leads to reduced opioid receptor function (tolerance), the mechanisms function (tolerance), the mechanisms through which this is achieved are not through which this is achieved are not certain and may include receptor internalisacertain and may include receptor internalisation or reduced receptor-effector coupling tion or reduced receptor-effector coupling (Williams (Williams et al et al, 2001) . , 2001). In vitro In vitro studies have studies have shown that chronic exposure to an opioid shown that chronic exposure to an opioid agonist can lead to a downregulation in agonist can lead to a downregulation in opioid receptors (Goodman opioid receptors (Goodman et al et al, 1996) . , 1996). However, this is not a consistent pattern However, this is not a consistent pattern in in in vivo in vivo studies, which have reported instudies, which have reported increases, decreases and no change in opioid creases, decreases and no change in opioid receptors, depending on the paradigm used receptors, depending on the paradigm used (Zadina (Zadina et al et al, 1995) . In humans, tolerance , 1995). In humans, tolerance to opioid agonists is well characterised but to opioid agonists is well characterised but there are virtually no data on brain opioid there are virtually no data on brain opioid receptor imaging. We have previously receptor imaging. We have previously demonstrated a dose-related reduction in demonstrated a dose-related reduction in opioid receptor function in people with opioid receptor function in people with opioid dependence who are on methadone opioid dependence who are on methadone maintenance by showing that they are less maintenance by showing that they are less sensitive to the effects of an opioid agonist, sensitive to the effects of an opioid agonist, hydromorphone (Melichar hydromorphone (Melichar et al et al, 2003) . , 2003). However, in a parallel [ However, in a parallel [ 11 11 C]-diprenorphine C]-diprenorphine PET study, we found no difference in bind-PET study, we found no difference in binding compared with a healthy control group, ing compared with a healthy control group, suggesting limited occupancy and no signifsuggesting limited occupancy and no significant changes in receptor number (Melichar icant changes in receptor number (Melichar et al et al, 2005) . This complements a study , 2005). This complements a study using [ using [ 18 18 F]-cyclofoxy PET that also sug-F]-cyclofoxy PET that also suggested that methadone requires only very gested that methadone requires only very low levels of opioid receptor occupancy low levels of opioid receptor occupancy for efficacy (Kling for efficacy (Kling et al et al, 2000) . Lastly, , 2000) . Lastly, post-mortem studies of people with heroin post-mortem studies of people with heroin dependence have shown inconsistent changes dependence have shown inconsistent changes (reduction or no difference) in (reduction or no difference) in m m opioid opioid receptor density compared with healthy receptor density compared with healthy controls (Gabilondo controls (Gabilondo et al et al, 1994; Ferrer-Alcon , 1994; Ferrer-Alcon et al et al, 2004) . These studies suggest that , 2004). These studies suggest that chronic opioid exposure might not alter chronic opioid exposure might not alter opioid receptor availability and importopioid receptor availability and importantly not increase receptor availability. antly not increase receptor availability.
Increased [ Increased [ 11 11 C]-diprenorphine C]-diprenorphine binding binding
The increase in [ The increase in [ 11 11 C]-diprenorphine binding C]-diprenorphine binding reflects an increase in availability of opioid reflects an increase in availability of opioid receptors to this PET tracer. Increased rereceptors to this PET tracer. Increased receptor affinity for the tracer could account ceptor affinity for the tracer could account for this increased availability, but there is for this increased availability, but there is no preclinical evidence that chronic opioid no preclinical evidence that chronic opioid administration alters affinity. Therefore, administration alters affinity. Therefore, the increase in [ the increase in [ 11 11 C]-diprenorphine binding C]-diprenorphine binding might be due to: (a) an increase in opioid might be due to: (a) an increase in opioid receptors during early abstinence from receptors during early abstinence from opioid drugs; (b) an increase in opioid opioid drugs; (b) an increase in opioid receptor number that develops with the receptor number that develops with the chronic use of an opioid agonist; (c) a rechronic use of an opioid agonist; (c) a reduction in competition from endogenous duction in competition from endogenous opioids. We believe that it is most likely opioids. We believe that it is most likely that our findings reflect a significant inthat our findings reflect a significant increase in opioid receptor number immedicrease in opioid receptor number immediately following detoxification from ately following detoxification from opioids. We know that withdrawal and opioids. We know that withdrawal and early abstinence is a time when the brain early abstinence is a time when the brain is under stress, and that such an increase is under stress, and that such an increase might represent a neuroadaptive response. might represent a neuroadaptive response. This would explain the similar findings This would explain the similar findings after cocaine and alcohol dependence after cocaine and alcohol dependence (Zubieta (Zubieta et al , et al ,1996 C]-diprenorphine binding C]-diprenorphine binding could also reflect increased opioid receptor could also reflect increased opioid receptor availability as a result of suppression of availability as a result of suppression of endogenous opioid release. Preclinical eviendogenous opioid release. Preclinical evidence shows that chronic treatment with dence shows that chronic treatment with methadone does not alter the concentration methadone does not alter the concentration or function of endogenous opioids, or function of endogenous opioids, although later studies with other opioids although later studies with other opioids and other drugs of misuse suggest that and other drugs of misuse suggest that endogenous opioids play a role in craving endogenous opioids play a role in craving or drug-seeking behaviour (for a review or drug-seeking behaviour (for a review see Gerrits see Gerrits et al et al, 2003) . Activation of the , 2003). Activation of the endogenous opioid system is associated endogenous opioid system is associated with the regulation of emotions, physical with the regulation of emotions, physical and emotional pain (Ribeiro and emotional pain (Ribeiro et al et al, 2005) . , 2005). A possibility is that the exogenous opioids A possibility is that the exogenous opioids used to alter emotions by people with used to alter emotions by people with opioid dependence might lead to suppresopioid dependence might lead to suppression of the endogenous opioid system and sion of the endogenous opioid system and consequently a compensatory upregulation consequently a compensatory upregulation of receptors. This would leave more of receptors. This would leave more receptors available for occupancy by receptors available for occupancy by [11C]-diprenorphine in early abstinence.
[11C]-diprenorphine in early abstinence. We are not aware of any human studies We are not aware of any human studies describing the impact of chronic opioid describing the impact of chronic opioid 6 6 6 6 agonist use on levels of endogenous agonist use on levels of endogenous opioids. opioids.
Opioid system after abstinence Opioid system after abstinence from substances from substances
In addition to being the primary target for In addition to being the primary target for opioid drugs, the opioid neurotransmitter opioid drugs, the opioid neurotransmitter system is important in initiating and mainsystem is important in initiating and maintaining dependence on a variety of misused taining dependence on a variety of misused substances (Herz, 1997 , 2000) . Therefore, it appears that similar in-2000). Therefore, it appears that similar increases in opioid receptor availability are creases in opioid receptor availability are seen during early abstinence from cocaine seen during early abstinence from cocaine and alcohol, and preliminary data suggest and alcohol, and preliminary data suggest a comparable increase in people with a comparable increase in people with opioid dependence. opioid dependence.
The evidence to date points to elevaThe evidence to date points to elevations in opioid binding being an acute effect tions in opioid binding being an acute effect of early abstinence, and our results in of early abstinence, and our results in opioid dependence complement these findopioid dependence complement these findings. It is not clear whether these changes ings. It is not clear whether these changes persist or even become additive with propersist or even become additive with progressive detoxifications. In cocaine depengressive detoxifications. In cocaine dependence, opioid receptor binding in some dence, opioid receptor binding in some but not all regions returns to control levels but not all regions returns to control levels within 1 week (Gorelick within 1 week (Gorelick et al et al, 2005 ). In , 2005 . In alcohol dependence the increase appears alcohol dependence the increase appears more persistent, with no reduction evident more persistent, with no reduction evident after 5 weeks of abstinence (Heinz after 5 weeks of abstinence (Heinz et al et al, , 2005) . It was not possible to scan our 2005). It was not possible to scan our participants after a period of abstinence participants after a period of abstinence owing to high relapse rates and strict resiowing to high relapse rates and strict residential rehabilitation programmes, but this dential rehabilitation programmes, but this would be valuable in future studies. would be valuable in future studies.
We found significant increases in [ We found significant increases in [ 11 11 C]-C]-diprenorphine binding in the majority of diprenorphine binding in the majority of regions analysed using the atlas, and signifregions analysed using the atlas, and significant increases in fusiform/parahippocampal icant increases in fusiform/parahippocampal gyri using exploratory voxel-based statistigyri using exploratory voxel-based statistical parametric mapping, although increases cal parametric mapping, although increases were seen throughout the brain when the were seen throughout the brain when the threshold for significance was lowered. It threshold for significance was lowered. It is not clear why an area incorporating the is not clear why an area incorporating the fusiform/parahippocampal gyri which is fusiform/parahippocampal gyri which is involved in processing visual associations involved in processing visual associations and memory was highlighted by statistical and memory was highlighted by statistical parametric mapping. We found no differparametric mapping. We found no difference in [ ence in [ 11 11 C]-diprenorphine binding be-C]-diprenorphine binding between people with opioid dependence and tween people with opioid dependence and controls in several of the controls in several of the a priori a priori areas, noareas, notably the periaqueductal grey matter (in the tably the periaqueductal grey matter (in the brain-stem), nucleus accumbens and caubrain-stem), nucleus accumbens and caudate. The template used for the brain-stem date. The template used for the brain-stem region is not precise enough to isolate the region is not precise enough to isolate the periaqueductal grey matter within the periaqueductal grey matter within the brain-stem region of interest, which may brain-stem region of interest, which may account for the lack of association there. account for the lack of association there. However, we are surprised to find no assoHowever, we are surprised to find no association with the nucleus accumbens and ciation with the nucleus accumbens and caudate in the light of previous findings of caudate in the light of previous findings of increased receptor number in these areas increased receptor number in these areas during withdrawal from cocaine and alcoduring withdrawal from cocaine and alcohol. In the two studies of cocaine depenhol. In the two studies of cocaine dependence, significant increases were seen in dence, significant increases were seen in the ventral striatum and the anterior cinguthe ventral striatum and the anterior cingulate, frontal and temporal cortices, caudate late, frontal and temporal cortices, caudate and thalamus (Zubieta and thalamus (Zubieta et al et al, 1996; , 1996; Gorelick Gorelick et al et al, 2005) , whereas in alcohol , 2005), whereas in alcohol dependence, significant increases were redependence, significant increases were restricted to the ventral striatum (Heinz stricted to the ventral striatum (Heinz et al et al, , 2005) . In people with opioid dependence 2005). In people with opioid dependence the changes were much more widespread, the changes were much more widespread, perhaps because of the direct pharmacoperhaps because of the direct pharmacological effect of opioids and possible logical effect of opioids and possible changes in the endogenous opioid system. changes in the endogenous opioid system.
Opioid receptor availability Opioid receptor availability and clinical variables and clinical variables
We found no correlation between craving We found no correlation between craving and opioid receptor availability, which is and opioid receptor availability, which is at variance with our hypothesis and preat variance with our hypothesis and previous findings in alcohol and cocaine devious findings in alcohol and cocaine dependence (Zubieta pendence (Zubieta et al et al, 1996; Gorelick , 1996; Gorelick et et al al, 2005; Heinz , 2005; Heinz et al et al, 2005) . Our parti-, 2005). Our participants with opioid dependence demoncipants with opioid dependence demonstrated high scores on two rating scales strated high scores on two rating scales for craving, which were comparable with for craving, which were comparable with those in a previous study (Weinstein those in a previous study (Weinstein et al et al, , 1997) and with individuals maintained on 1997) and with individuals maintained on methadone who had withdrawal induced methadone who had withdrawal induced by naloxone (Schuster by naloxone (Schuster et al et al, 1995) but were , 1995) but were higher than scores for people maintained on higher than scores for people maintained on methadone (Schuster methadone (Schuster et al et al, 1995) . Further-, 1995) . Furthermore, our participants experienced levels more, our participants experienced levels of and variance in craving scores that were of and variance in craving scores that were comparable with earlier studies in which comparable with earlier studies in which craving was induced and resulting brain craving was induced and resulting brain activation detected (Daglish activation detected (Daglish et al et al, 2001) . , 2001). Craving measures vary and so comparison Craving measures vary and so comparison with other studies is hampered. However, with other studies is hampered. However, in our study we chose two commonly used in our study we chose two commonly used scales with a total of seven craving subscales with a total of seven craving subscales, so the absence of a correlation here scales, so the absence of a correlation here is robust. is robust. Opioid receptor binding levels were not Opioid receptor binding levels were not related to withdrawal symptoms as found related to withdrawal symptoms as found in cocaine and alcohol dependence (Zubieta in cocaine and alcohol dependence (Zubieta et al et al, 1996; Gorelick , 1996; Gorelick et al et al, 2005) . This is , 2005). This is consistent with the clinical picture where consistent with the clinical picture where opioid withdrawal can be ameliorated by opioid withdrawal can be ameliorated by non-opioid pharmacotherapy. We did not non-opioid pharmacotherapy. We did not find a correlation between age and opioid find a correlation between age and opioid receptor levels in either the group with receptor levels in either the group with opioid dependence or controls. In a [ opioid dependence or controls. In a [ 11 11 C]-C]-carfentanil PET study of healthy controls carfentanil PET study of healthy controls with a wider age range, increasing age with a wider age range, increasing age was associated with higher opioid receptor was associated with higher opioid receptor levels in the neocortex (Zubieta levels in the neocortex (Zubieta et al et al, , 1999) . Our more limited age range and 1999). Our more limited age range and younger average age likely contributed to younger average age likely contributed to the absence of such a correlation. All of the absence of such a correlation. All of our group with dependence were tobacco our group with dependence were tobacco smokers and controls were current nonsmokers and controls were current nonsmokers, but there was no correlation besmokers, but there was no correlation between quantity of cigarettes smoked and tween quantity of cigarettes smoked and [ [ 11 11 C]-diprenorphine binding. Furthermore, C]-diprenorphine binding. Furthermore, another study of alcoholism reported no another study of alcoholism reported no significant interaction between smoking significant interaction between smoking status and status and m m opioid receptor availability in opioid receptor availability in patients and controls (Heinz patients and controls (Heinz et al et al, 2005) . , 2005).
Limitations Limitations
Although this study was appropriately Although this study was appropriately powered to detect the measured effect in a powered to detect the measured effect in a PET study of this nature, it may have been PET study of this nature, it may have been underpowered to determine associations underpowered to determine associations with clinical variables, especially craving. with clinical variables, especially craving. The studies reporting an association beThe studies reporting an association between craving and opioid receptor levels tween craving and opioid receptor levels had dependent groups of 10, 17 and 25 rehad dependent groups of 10, 17 and 25 respectively (Zubieta spectively (Zubieta et al et al, 1996; Gorelick , 1996; Gorelick et et al al, 2005; Heinz , 2005; Heinz et al et al, 2005) . However, the , 2005). However, the participants in our study were craving at participants in our study were craving at similar levels and with a wide range of similar levels and with a wide range of craving scores, making it likely that any craving scores, making it likely that any association should have been apparent. association should have been apparent.
Implications Implications
We have reported a significant widespread We have reported a significant widespread increase in brain opioid receptor availabilincrease in brain opioid receptor availability in people with opioid dependence durity in people with opioid dependence during early abstinence from methadone. ing early abstinence from methadone. Together with previous evidence, we argue Together with previous evidence, we argue that this reflects an increase after cessation that this reflects an increase after cessation of methadone rather than a chronic change. of methadone rather than a chronic change. If this is the case, it could give us a crucial If this is the case, it could give us a crucial insight into the mechanisms that underlie insight into the mechanisms that underlie opioid craving. Although clinically we opioid craving. Although clinically we know that substitution treatment is effecknow that substitution treatment is effective we do not know whether prolonged tive we do not know whether prolonged agonist exposure permanently alters brain agonist exposure permanently alters brain neurochemistry and whether these changes neurochemistry and whether these changes hamper recovery. Furthermore, since such hamper recovery. Furthermore, since such an increase in opioid receptors has also an increase in opioid receptors has also been shown in alcohol and cocaine depenbeen shown in alcohol and cocaine dependence, this argues for a fundamental role dence, this argues for a fundamental role of the opioid system in addiction, or at least of the opioid system in addiction, or at least in the early abstinence syndrome. The conin the early abstinence syndrome. The contribution of this to clinical states and tribution of this to clinical states and treatment outcomes has yet to be fully treatment outcomes has yet to be fully characterised. characterised.
